Artificial Intelligence healthcare developer Viz.ai said yesterday it won FDA 510(k) clearance for its Viz CTP computed tomography perfusion image processing and analysis software.
The San Francisco-based company said that the software compliments its current offerings, which include automated large vessel occlusion stroke identification, stroke triage and LVO notification, patient selection, medical image viewing, transport coordination and HIPAA-compliant communications..
“In stroke, good patient outcomes can come down to a matter of minutes. We are proud to offer hospital systems a comprehensive solution that can facilitate end-to-end care coordination and create efficiencies in acute stroke pathways to help get the right patient to the right doctor at the right time,” CEO & co-founder Dr. Chris Mansi said in a press release.
In February, Viz.ai said it won approval from the FDA for its LVO Stroke platform designed to analyze computed tomography results and notify providers of potential strokes, touting it as the first such system to win FDA clearance.